Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul;17(7):336-339.

Overview of Hepatitis B Virus Reactivation

Robert Perrillo  1
Affiliations

Overview of Hepatitis B Virus Reactivation

Robert Perrillo. Gastroenterol Hepatol (N Y). 2021 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosures: Dr Perrillo has no relevant conflicts of interest to disclose.

References

    1. Gonzalez SA, Perrillo RP. Hepatitis B virus reactivation in the setting of cancer chemotherapy and other immunosuppressive drug therapy. Clin Infect Dis. 2016;62(suppl 4):S306–S313. - PMC - PubMed
    1. Loomba R, Liang TJ. Hepatitis B reactivation associated with immune suppressive and biological modifier therapies: current concepts, management strategies, and future directions. Gastroenterology. 2017;152(6):1297–1309. - PMC - PubMed
    1. Paul S, Dickstein A, Saxena A et al. Role of surface antibody in hepatitis B reactivation in patients with resolved infection and hematologic malignancy: a metaanalysis. Hepatology. 2017;66(2):379–388. - PMC - PubMed
    1. Perrillo RP, Gish R, Falck-Ytter YT. American Gastroenterological Association Institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy. Gastroenterology. 2015;148(1):221–244. e3. - PubMed
    1. Terrault NA, Lok ASF, McMahon BJ et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560–1599. - PMC - PubMed

LinkOut - more resources